This competitive renewal continues to explore the general hypothesis (a) that surface expressed proteins control the interactions of endothelial cells with blood molecules, with adjacent ECs and with underlying matrix and cells of the vessel wall and tissues, and (b) that expression and organization of these surface proteins are regulated by extracellular signals such as cytokines. Surface proteins localized to the intercellular junctions of ECs control vascular permeability. The renewal will focus on the role of tight junction (TJ) proteins, especially claudin 5, in human capillary ECs, and how TJs (and claudin 5) are affected by the pro-inflammatory cytokine, tumor necrosis factor (TNF). The specific hypothesis to be tested has three components: (a) that disruption of TJs in ECs that line the continuous capillaries in sepsis and related conditions produces capillary leak, a major mechanism of organ injury and dysfunction;(b) that TNF, a major mediator of sepsis, causes capillary leak by disrupting TJs either by altering the expression or organization of proteins that directly form TJs or that control TJ organization through the actin cytoskeleton;and (c) that KLF4, a transcription factor induced in capillary ECs by laminar shear stress, can regulate the pathological effects of TNF on capillary TJs. This hypothesis will be explored in three specific aims. First, we will characterize the organization of TJs, with emphasis on the role of claudin 5, in human continuous capillary ECs and determine how TJ proteins interact with each other and with the actin cytoskeleton. Second, we will determine how TNF affects the organization of human capillary TJ proteins and identify those proteins whose expression levels are changed by TNF, resulting in TJ disruption and capillary leak. Third, we will determine how KLF4 regulates TNF-induced changes in capillary ECs and if this can be exploited to control TNF-induced pathological changes. In these experiments we will manipulate gene expression of cultured human microvascular ECs and compare with other EC systems to analyze structure and function of TJs in vitro, making use of ECIS measurements of transendothelial electrical resistance as a key functional assay. We also will examine intact human tissues and experimentally manipulate human capillaries in vivo by engrafting immuno-deficient mice with vascularized human skin or with synthetic microvascular beds constructed from wild type and genetically altered human ECs. Successful completion of these aims may lead to effective therapeutic approaches to control capillary leak.

Public Health Relevance

Sepsis and related syndromes affect over 750,000 persons per year in the U.S. and death rates in severe sepsis or septic shock, the most serious forms of this disorder, are very high (over 30%). We propose that the leaking of fluid from the blood capillaries into the tissues, which is a feature of sepsis and for which there is no currently effective treatment, is caused by tumor necrosis factor, one of the principal mediators of sepsis, acting on the blood capillaries. Our investigation into the mechanisms of TNF-induced capillary leak may provide a basis for new and effective therapies that will reduce organ failure and death in patients with sepsis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL036003-27
Application #
8289873
Study Section
Atherosclerosis and Inflammation of the Cardiovascular System Study Section (AICS)
Program Officer
Gao, Yunling
Project Start
1991-07-01
Project End
2016-03-31
Budget Start
2012-04-01
Budget End
2013-03-31
Support Year
27
Fiscal Year
2012
Total Cost
$508,345
Indirect Cost
$182,960
Name
Yale University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Al-Lamki, Rafia S; Lu, Wanhua; Wang, Jun et al. (2013) TNF, acting through inducibly expressed TNFR2, drives activation and cell cycle entry of c-Kit+ cardiac stem cells in ischemic heart disease. Stem Cells 31:1881-92
Kluger, Martin S; Clark, Paul R; Tellides, George et al. (2013) Claudin-5 controls intercellular barriers of human dermal microvascular but not human umbilical vein endothelial cells. Arterioscler Thromb Vasc Biol 33:489-500
D'Alessio, Alessio; Esposito, Bianca; Giampietri, Claudia et al. (2012) Plasma membrane microdomains regulate TACE-dependent TNFR1 shedding in human endothelial cells. J Cell Mol Med 16:627-36
Pober, Jordan S; Tellides, George (2012) Participation of blood vessel cells in human adaptive immune responses. Trends Immunol 33:49-57
Clark, Paul R; Jensen, Todd J; Kluger, Martin S et al. (2011) MEK5 is activated by shear stress, activates ERK5 and induces KLF4 to modulate TNF responses in human dermal microvascular endothelial cells. Microcirculation 18:102-17
D'Alessio, Alessio; Kluger, Martin S; Li, Jie H et al. (2010) Targeting of tumor necrosis factor receptor 1 to low density plasma membrane domains in human endothelial cells. J Biol Chem 285:23868-79
Suarez, Yajaira; Wang, Chen; Manes, Thomas D et al. (2010) Cutting edge: TNF-induced microRNAs regulate TNF-induced expression of E-selectin and intercellular adhesion molecule-1 on human endothelial cells: feedback control of inflammation. J Immunol 184:21-5
Al-Lamki, Rafia S; Sadler, Timothy J; Wang, Jun et al. (2010) Tumor necrosis factor receptor expression and signaling in renal cell carcinoma. Am J Pathol 177:943-54
Al-Lamki, R S; Brookes, A P; Wang, J et al. (2009) TNF receptors differentially signal and are differentially expressed and regulated in the human heart. Am J Transplant 9:2679-96
Li, Jie H; D'Alessio, Alessio; Pober, Jordan S (2009) Lipopolysaccharide can trigger a cathepsin B-dependent programmed death response in human endothelial cells. Am J Pathol 175:1124-35

Showing the most recent 10 out of 73 publications